573 Pill: blue & white, oval
The pill with imprint 573 (Blue & White, Oval, 0mm) has been identified as Levetiracetam Extended-Release 500 mg and is used for Seizures, and Epilepsy. It belongs to the drug class pyrrolidine anticonvulsants and is not a controlled substance.
Images for 573
Levetiracetam Extended-Release
- Imprint
- 573
- Strength
- 500 mg
- Color
- Blue & White
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Pyrrolidine anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sun Pharma Global FZE
- National Drug Code (NDC)
- 47335-0573
- Inactive Ingredients
-
povidone k90,
hypromellose 2208 (15000 mPa.s),
dimethylaminoethyl methacrylate - butyl methacrylate - methyl methacrylate copolymer,
silicon dioxide,
magnesium stearate,
magnesium silicate,
crospovidone,
sodium lauryl sulfate,
FD&C Blue No. 1,
ethylcellulose,
dibutyl sebacate,
triethyl citrate,
polysorbate 20,
polyvinyl alcohol,
polyethylene glycol 3350,
polysorbate 80
Note: Inactive ingredients may vary.
Related images for "573"
More about levetiracetam
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (434)
- Drug images
- Latest FDA alerts (6)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: pyrrolidine anticonvulsants
- Breastfeeding
- En español
Patient resources
- Levetiracetam oral/injection drug information
- Levetiracetam Extended-Release Tablets
- Levetiracetam Tablets
- Levetiracetam Injection
- Levetiracetam Oral Solution
Other brands
Keppra, Keppra XR, Spritam, Elepsia XR, ... +2 more
Professional resources
- Levetiracetam monograph
- Levetiracetam (FDA)
- Levetiracetam Extended Release Tablets (FDA)
- Levetiracetam Injection (FDA)
- Levetiracetam Injection, Concentrate (FDA)
- Levetiracetam Solution (FDA)
Other brands
Keppra, Keppra XR, Spritam, Elepsia XR, ... +2 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.